Convicted fraudster Martin Shkreli is sentenced for securities fraud related to two hedge funds he ran and to his former drug company Retrophin. The notorious "pharma bro" gained infamy for raising the price of the drug Daraprim by more than 5,000 percent while running the company then known as Turing Pharmaceuticals.